Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
NCT00241085 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 392
Last updated 2011-11-08
Summary
This is a study of whether valsartan affects levels of proteinuria in patients with type 2 diabetes and hypertension.
Conditions
- PROTEINURIA
- Hypertension
- Type 2 Diabetes
Interventions
- DRUG
-
valsartan
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-11-30
- Primary Completion
- 2005-08-31
- Completion
- 2005-08-31
More Related Trials
-
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
NCT00171119 ·Status: TERMINATED ·Phase: PHASE4
-
The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure
NCT00241098 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Valsartan on Carotid Artery Disease
NCT00208767 ·Status: COMPLETED ·Phase: PHASE2
-
Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
NCT05545059 ·Status: UNKNOWN ·Phase: PHASE3
-
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
NCT00190580 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
NCT00171353 ·Status: COMPLETED ·Phase: PHASE4
-
The DDI Study of SP2086 and Valsartan
NCT02817217 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
NCT00241137 ·Status: COMPLETED ·Phase: PHASE3
-
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
NCT00170924 ·Status: COMPLETED ·Phase: PHASE4
-
The Drug-drug Interaction of SP2086 and Valsartan
NCT02815657 ·Status: COMPLETED ·Phase: PHASE1
-
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
NCT00902304 ·Status: COMPLETED ·Phase: PHASE4
-
VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis
NCT00171080 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
NCT00171561 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
NCT00241124 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
NCT01095822 ·Status: UNKNOWN ·Phase: PHASE4
-
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
NCT01609959 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
NCT00385931 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)
NCT01390415 ·Status: COMPLETED
-
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
NCT00394745 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
NCT01617681 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
NCT00170989 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
NCT00591578 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
NCT00171041 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
NCT06395194 ·Status: COMPLETED ·Phase: PHASE3